全文获取类型
收费全文 | 694篇 |
免费 | 24篇 |
国内免费 | 7篇 |
专业分类
儿科学 | 260篇 |
妇产科学 | 4篇 |
基础医学 | 44篇 |
口腔科学 | 9篇 |
临床医学 | 31篇 |
内科学 | 114篇 |
皮肤病学 | 8篇 |
神经病学 | 17篇 |
特种医学 | 153篇 |
外科学 | 25篇 |
综合类 | 6篇 |
预防医学 | 8篇 |
眼科学 | 4篇 |
药学 | 16篇 |
肿瘤学 | 26篇 |
出版年
2021年 | 5篇 |
2020年 | 2篇 |
2019年 | 7篇 |
2018年 | 6篇 |
2016年 | 4篇 |
2015年 | 9篇 |
2014年 | 15篇 |
2013年 | 13篇 |
2012年 | 10篇 |
2011年 | 20篇 |
2010年 | 39篇 |
2009年 | 31篇 |
2008年 | 33篇 |
2007年 | 24篇 |
2006年 | 30篇 |
2005年 | 34篇 |
2004年 | 27篇 |
2003年 | 9篇 |
2002年 | 7篇 |
2001年 | 10篇 |
2000年 | 5篇 |
1999年 | 11篇 |
1998年 | 32篇 |
1997年 | 27篇 |
1996年 | 29篇 |
1995年 | 26篇 |
1994年 | 17篇 |
1993年 | 19篇 |
1992年 | 4篇 |
1991年 | 7篇 |
1990年 | 11篇 |
1989年 | 17篇 |
1988年 | 18篇 |
1987年 | 14篇 |
1986年 | 18篇 |
1985年 | 21篇 |
1984年 | 11篇 |
1983年 | 16篇 |
1982年 | 22篇 |
1981年 | 9篇 |
1980年 | 14篇 |
1979年 | 1篇 |
1978年 | 5篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 5篇 |
1974年 | 1篇 |
1972年 | 2篇 |
1970年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有725条查询结果,搜索用时 640 毫秒
51.
52.
53.
Y-H Cha H Lee LS Santell & RW Baloh 《Cephalalgia : an international journal of headache》2009,29(5):550-555
The aim of this study was to determine the association of benign recurrent vertigo (BRV) and migraine, using standardized questionnaire-based interview of 208 patients with BRV recruited through a University Neurotology clinic. Of 208 patients with BRV, 180 (87%) met the International Classification of Headache Disorders 2004 criteria for migraine: 112 migraine with aura (62%) and 68 without aura (38%). Twenty-eight (13%) did not meet criteria for migraine. Among patients with migraine, 70% experienced headache, one or more auras, photophobia, or auditory symptoms with some or all of their vertigo attacks, meeting the criteria for definite migrainous vertigo. Thirty per cent never experienced migraine symptoms concurrent with vertigo attacks. These met criteria for probable migrainous vertigo. Among patients without migraine, 21% experienced either photophobia or auditory symptoms with some or all of their vertigo attacks; 79% experienced only isolated vertigo. The age of onset and duration of vertigo attacks did not differ significantly between patients with (34 ± 1.2 years) and patients without migraine (31 ± 3.0 years). In patients with migraine, the age of onset of migraine headache preceded the onset of vertigo attacks by an average of 14 years and aura preceded vertigo by 8 years. The most frequent duration of vertigo attacks was between 1 h and 1 day. Benign recurrent vertigo is highly associated with migraine, but a high proportion of patients with BRV and migraine never have migraine symptoms during their vertigo attacks. Other features such as age of onset and duration of vertigo are similar between patients with or without migraine. 相似文献
54.
55.
56.
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis 总被引:4,自引:0,他引:4
Gibson RL Emerson J McNamara S Burns JL Rosenfeld M Yunker A Hamblett N Accurso F Dovey M Hiatt P Konstan MW Moss R Retsch-Bogart G Wagener J Waltz D Wilmott R Zeitlin PL Ramsey B;Cystic Fibrosis Therapeutics Development Network Study Group 《American journal of respiratory and critical care medicine》2003,167(6):841-849
We conducted a double-blind, placebo-controlled, multicenter, randomized trial to test the hypothesis that 300 mg of tobramycin solution for inhalation administered twice daily for 28 days would be safe and result in a profound decrease in Pseudomonas aeruginosa (Pa) density from the lower airway of young children with cystic fibrosis. Ninety-eight subjects were to be randomized; however, the trial was stopped early because of evidence of a significant microbiological treatment effect. Twenty-one children under age 6 years were randomized (8 active; 13 placebo) and underwent bronchoalveolar lavage at baseline and on Day 28. There was a significant difference between treatment groups in the reduction in Pa density; no Pa was detected on Day 28 in 8 of 8 active group patients compared with 1 of 13 placebo group patients. We observed no differences between treatment groups for clinical indices, markers of inflammation, or incidence of adverse events. No abnormalities in serum creatinine or audiometry and no episodes of significant bronchospasm were observed in association with active treatment. We conclude that 28 days of tobramycin solution for inhalation of 300 mg twice daily is safe and effective for significant reduction of lower airway Pa density in young children with cystic fibrosis. 相似文献
57.
58.
MH Galea DM FRCS Professor RW Blamey MD FRCS 《Breast cancer research and treatment》1993,28(3):299-300
on behalf of the Nottingham Breast Unit 相似文献
59.
OBJECTIVE--To determine the prevalence of behaviour disorders in low birthweight infants. DESIGN--Children of birth weight < or = 2000 g born to mothers resident in Merseyside in 1980-1 assessed using the Rutter parent and teacher behaviour questionnaires and the Conner modification of the Rutter teacher questionnaire. Children attending normal schools were assessed with controls matched for age, sex, and class in school. Children attending special schools were assessed unmatched. SUBJECTS--233 matched case-control pairs attending normal primary schools and 46 unmatched children attending special schools. SETTING--Primary and special schools. MAIN OUTCOME MEASURES--Emotional, conduct, and undifferentiated behaviour disorders and hyperactivity. RESULTS--On the parental questionnaire screen, 36% of the cases and 22% of the controls had a behaviour disorder and on the teacher questionnaire the proportions were 27% and 12% respectively. Hyperactivity was significantly more common among male cases than their controls (21% v 5.0%) but differed little among female cases and controls (9% v 7%). CONCLUSIONS--Improving neonatal survival of low birthweight infants is accompanied by a higher prevalence of behaviour disorders. The long term implications for psychiatric morbidity and other adult disease must be monitored. 相似文献
60.
Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis 总被引:4,自引:0,他引:4
Smith AL Doershuk C Goldmann D Gore E Hilman B Marks M Moss R Ramsey B Redding G Rubio T Williams-Warren J Wilmott R Wilson HD Yogev R 《The Journal of pediatrics》1999,134(4):413-421
We determined whether a beta-lactam and an aminoglycoside have efficacy greater than a beta-lactam alone in the management of a pulmonary exacerbation in patients with cystic fibrosis.Study design: Azlocillin and placebo or azlocillin and tobramycin were administered to 76 patients with a pulmonary exacerbation caused by Pseudomonas aeruginosa in a randomized double-blind, third-party monitored protocol. Improvement was assessed by standardized clinical evaluation, pulmonary function testing, sputum bacterial density, sputum DNA content, and time to the next pulmonary exacerbation requiring hospitalization. RESULTS: No significant difference was seen between the 2 treatment groups in clinical evaluation, sputum DNA concentration, forced vital capacity, forced expiratory volume in second 1, or peak expiratory flow rate at the end of treatment (33 receiving azlocillin alone and 43 both antibiotics); adverse reactions were equivalent in each group. Sputum P. aeruginosa density decreased more with combination therapy (P =.034). On follow-up evaluation, an average of 26 days after the end of treatment, all outcome indicators had worsened in both groups. Time to readmission for a new pulmonary exacerbation was significantly longer in the group receiving azlocillin plus tobramycin (P <.001). Treatment-emergent tobramycin resistance occurred in both groups and was more frequent with combination therapy. CONCLUSION: We conclude that the combination of a beta-lactam and an aminoglycoside produces a longer clinical remission than a beta-lactam alone and slightly better initial improvement. 相似文献